Implementing In Vivo Disease Models in Treatment Analysis to Assess the Quality of Developing Treatments
Time: 4:30 pm
day: Conference Day One PM
Details:
- Discussing the ability of GvHD and IBD mouse models in replicating complex immunecell interactions
- Exploring the potential of mouse models to assess treatment efficacy, persistence and safety
- Highlighting IL-10 expressing cell therapy preclinical data showcasing efficacy using preclinical models
